Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHA2 | P29317 | 2/20 | 0.65 |
| ▸ | TFPI | P10646 | 5/20 | 0.63 |
| ▸ | NPY2R | P49146 | 7/20 | 0.60 |
| ▸ | NPY4R | P50391 | 7/20 | 0.60 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.60 |
| ▸ | NPY1R | P25929 | 5/20 | 0.60 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.58 |
| ▸ | RAMP3 | O60896 | 1/20 | 0.58 |
| ▸ | CALCR | P30988 | 1/20 | 0.58 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.58 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.58 |
| ▸ | KDM1A | O60341 | 1/20 | 0.56 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30415150 | 0.98 | EPHA2 (0.62) | EPHA2TFPINPY2RNPY4RNPY5R | |
| SCHEMBL30415381 | 0.97 | EPHA2 (0.65) | EPHA2TFPINPY2RNPY4RNPY5R | |
| SCHEMBL30415710 | 0.97 | EPHA2 (0.65) | EPHA2TFPINPY2RNPY4RNPY5R | |
| SCHEMBL30186412 | 0.97 | EPHA2 (0.65) | EPHA2TFPINPY2RNPY4RNPY5R | |
| Rusalatide SCHEMBL29392126 | 0.95 | EPHA2 (0.62) | EPHA2TFPINPY2RNPY4RNPY5R | |
| SCHEMBL29390108 | 0.95 | EPHA2 (0.62) | EPHA2TFPINPY2RNPY4RNPY5R | |
| Rusalatide SCHEMBL29357268 | 0.94 | TFPI (0.62) | EPHA2TFPINPY2RNPY4RNPY5R | |
| SCHEMBL31473050 | 0.94 | CXCR4 (0.61) | EPHA2TFPINPY2RNPY4RNPY5R | |
| SCHEMBL29392765 | 0.91 | EPHA2 (0.57) | EPHA2TFPINPY2RNPY4RNPY5R | |
| SCHEMBL30607473 | 0.90 | NPY2R (0.63) | EPHA2TFPINPY2RNPY4RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230165943-A1 | TP508 ACUTE THERAPY FOR PATIENTS WITH RESPIRATORY VIRUS INFECTION | CHRYSALIS BIOTHERAPEUTICS, INC. | 2023-06-01 | — | — | US | disclosed |